logo
Share SHARE
FONT-SIZE Plus   Neg

Syneron Medical Acquires Ultrashape - Quick Facts

Aesthetic device company Syneron Medical Ltd. (ELOS) announced Friday that it has closed the acquisition of Ultrashape Ltd., a manufacturer of non-invasive technologies for fat cell destruction and body sculpting.

The integration of Ultrashape business will begin immediately and its products will now be available through Syneron's worldwide network of direct and distributor sales channels.

Louis P. Scafuri, CEO of Syneron Medical, said, "The addition of Ultrashape's unique focused ultrasound technology will provide Syneron immediate entry into the large and attractive global market for fat cell destruction and body sculpting. Ultrashape's technology provides a differentiated, physician and patient friendly, non-invasive treatment for de-bulking and body sculpting of normal to overweight patients."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Morgan Stanley (MS) reported fourth-quarter net income applicable to company of $1.7 billion, or $0.81 per share compared with income of $908 million, or $0.39 per share, for the same period a year ago. On average, 24 analysts polled by Thomson Reuters expected the company to report profit per share... A federal judge this week ruled in favor of media company Viacom, stating that the fictional restaurant "The Krusty Krab" in the animated television series "SpongeBob SquarePants" is worthy of trademark protection. SpongeBob is aired by Viacom's Nickelodeon cable network. British American Tobacco plc Tuesday said it has agreed to buy the remaining 57.8 percent of Reynolds American Inc. it does not already own in $49.4 billion cash and stock deal. The companies said the deal would create a stronger, truly global tobacco and Next Generation Products company. The British tobacco major currently owns 42.2 percent of Reynolds.
comments powered by Disqus
Follow RTT